Hers tirzepatide is a compounded weight loss option from Hims & Hers. Learn how it works, what it costs, dosing basics, and safety facts to know.
Hers tirzepatide refers to a compounded tirzepatide injection that was offered through the Hers weight loss program, operated by telehealth company Hims & Hers Health. It used the same active ingredient found in Zepbound and Mounjaro, but it was never an FDA-approved product and it was never a generic version of either brand. Availability has changed sharply since the FDA resolved the tirzepatide shortage, so anyone searching for Hers tirzepatide today should confirm current options with the company or a licensed prescriber.
What "Hers Tirzepatide" Actually Means
Hers is the women-focused brand of Hims & Hers Health, a US telehealth platform that sells prescription treatments after an online consultation. During the GLP-1 shortage, the company worked with licensed compounding pharmacies to offer compounded semaglutide and compounded tirzepatide at monthly prices well below brand-name list prices.
Compounded tirzepatide is not the same thing as Zepbound. A compounded drug is prepared by a pharmacy under a prescription, and it does not go through FDA review for safety, effectiveness, or manufacturing quality the way a brand-name product does.
| Feature | Hers compounded tirzepatide | Zepbound (brand) |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| FDA approval | Not FDA-approved as a compounded product | FDA-approved for chronic weight management |
| Who makes it | A state-licensed compounding pharmacy | Eli Lilly |
| Typical form | Vial and syringe, patient draws the dose | Single-dose pen or single-dose vial |
| Typical cost during the shortage | Roughly $199–$299 per month | $1,000+ per month list price without insurance |
Tirzepatide is not available as a generic in the United States. No FDA-approved generic version of tirzepatide exists, so any low-cost tirzepatide is either brand-name product sold at a discount or a compounded preparation.
How Tirzepatide Works and How It Is Dosed
Tirzepatide is a dual GIP and GLP-1 receptor agonist given as a once-weekly subcutaneous injection. It reduces appetite and slows stomach emptying, which is why it is approved for weight management in adults with obesity or with excess weight plus at least one related health condition.
Treatment starts at a low dose and increases roughly every four weeks to limit side effects. Dose changes should always be directed by a licensed prescriber who knows your history and other medications.
| Weeks of treatment | Typical weekly dose |
|---|---|
| Weeks 1–4 | 2.5 mg |
| Weeks 5–8 | 5 mg |
| Weeks 9–12 | 7.5 mg |
| Weeks 13–16 | 10 mg |
| Weeks 17–20 | 12.5 mg |
| Week 21 and beyond | 15 mg (maximum recommended dose) |
Hers shipped compounded tirzepatide in single-use vials with syringes rather than in the auto-injector pens used for Zepbound. That means patients drew up their own dose, which adds a step that brand-name pens do not require and increases the chance of a measuring error.
Cost, Insurance, and Current Availability
Pricing was the main draw of compounded GLP-1s, and monthly plans through telehealth platforms generally landed between $199 and $299. Brand-name Zepbound lists for more than $1,000 per month without insurance, though Eli Lilly sells single-dose vials of the 2.5 mg and 5 mg strengths for roughly $349 to $499 per month through its own pharmacy program.
| Option | What it is | Approx. monthly cost | FDA-approved? |
|---|---|---|---|
| Hers compounded tirzepatide | Compounded injection from a licensed pharmacy | $199–$299 during the shortage | No |
| Zepbound pens | Brand tirzepatide auto-injector | $1,000+ without insurance | Yes |
| Zepbound single-dose vials | Brand tirzepatide vials via LillyDirect | About $349–$499 | Yes |
| Compounded semaglutide (Hers) | A different active ingredient | Starts around $199 | No |
The FDA declared the tirzepatide shortage resolved in late 2024, and in 2025 federal courts allowed enforcement against large-scale compounding to move forward. As a result, most large telehealth companies, including Hims & Hers, wound down broad compounded tirzepatide offerings.
Limited compounding can still happen. A state-licensed 503A pharmacy may prepare tirzepatide for an individual patient when a prescriber documents a specific clinical need, such as an allergy to an ingredient in the commercial product or a dose strength that is not manufactured.
Insurance coverage for weight loss medication varies widely. Many commercial plans exclude GLP-1 drugs for weight loss, and Medicare Part D does not cover them for that indication.
Side Effects and Safety Considerations
Common side effects of tirzepatide include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and injection-site reactions. Most of these are mild and ease as the body adjusts, but dehydration from persistent vomiting can become serious.
Serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and gastroparesis. Tirzepatide carries a boxed warning about thyroid C-cell tumors and should not be used by anyone with a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Tirzepatide is not recommended during pregnancy, and anyone planning a pregnancy should stop the medication ahead of time under medical guidance. People with a history of pancreatitis, gallbladder disease, or kidney problems should talk through the risks with a clinician before starting.
Add-Ons, Alternatives, and Other Questions People Ask
Many people compare tirzepatide with other incretin-based options. Cagrilintide is an investigational amylin analog studied in combination with semaglutide, not tirzepatide, so a direct comparison like cagrilintide vs tirzepatide is largely hypothetical at this stage. Retatrutide, a triple agonist, is also still in clinical trials and is not FDA-approved for any use.
Some clinics market "fat burner" injections alongside GLP-1 medication, including lipo c with b12 with tirzepatide or aod 9604 with tirzepatide. Neither Lipo-C, a methionine, inositol, and choline blend, nor AOD 9604 is FDA-approved for weight loss, and the evidence for pairing either one with tirzepatide is thin.
Another common question involves handling lyophilized powder instead of a prescription product. People who buy unapproved powder online often search for how much bac water to reconstitute 20mg tirzepatide, but mixing powder at home carries real risks: dosing errors, contamination, and no guarantee of what is actually in the vial.
How to Get Tirzepatide Legally in the US
The straightforward legal path to tirzepatide is a prescription for an FDA-approved product: Zepbound for weight management or Mounjaro for type 2 diabetes. Telehealth visits, including those offered by Hims & Hers, can connect patients with licensed prescribers, but any medication dispensed still has to follow federal compounding rules.
Before paying for any program, ask three questions: Who writes the prescription? Which pharmacy fills it? Is the product FDA-approved? If the last answer is no, you are accepting more uncertainty about purity, potency, and dosing accuracy.
Anyone considering tirzepatide should talk with a licensed healthcare professional about personal risks, side effects, and whether a GLP-1 medication is appropriate for their health situation.
Frequently Asked Questions
Is Hers tirzepatide the same as Zepbound?
Both contain the active ingredient tirzepatide, but Hers sold a compounded version prepared by a licensed compounding pharmacy, while Zepbound is an FDA-approved product made by Eli Lilly. Compounded tirzepatide is not FDA-approved and is not a generic. Availability of compounded tirzepatide through large telehealth platforms has been sharply limited since the FDA resolved the shortage.
How much did Hers tirzepatide cost?
Monthly pricing for compounded GLP-1 medications through Hims & Hers generally started around $199 to $299, which was well below Zepbound's list price of more than $1,000 per month without insurance. Exact pricing changed over time and varied by plan and dose. Check the company's website for current weight loss offerings, since compounded tirzepatide was discontinued as federal rules tightened.
Can I still get compounded tirzepatide in 2025?
Broad compounding of tirzepatide largely ended after the FDA declared the shortage resolved and courts allowed enforcement to proceed. Some state-licensed 503A pharmacies may still compound it in limited, patient-specific cases with a valid prescription, such as a documented allergy to an ingredient in the brand product. Ask a prescriber or pharmacist what is allowed in your state.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.